Table 6.
Outcomes | Model | 1 | 2 | 3 | 4 | 5 | 6 |
---|---|---|---|---|---|---|---|
DCR
Class 0: PD Class 1: SD+PR+CR |
CatBoost | NLR | IO/IOCT | Line of IO | LDH | Age | PD-L1 |
Logistic
Regression |
IO/IOCT | PD-L1 | NLR | TNMio | ECOG PS | RT | |
OS6
Class 0/1: <6/≥6 months |
CatBoost | ECOG PS | NLR | ANC | TNMio | LDH | AMC |
Logistic
Regression |
ECOG PS | Line of IO | TNMio | NLR | Histology | AMC | |
TTF3
Class 0/1: <3/≥3 months |
CatBoost | NLR | ECOG PS | TNMio | IO/IOCT | AMC | LDH |
Logistic
Regression |
NLR | IO/IOCT | ECOG PS | PD-L1 | TNMio | AMC |
IO/IOCT, Immunotherapy alone vs chemo-immunotherapy combination.
The position of the features from 1 to 6 is determined based on the most important feature in terms of Shap Value. The red color is assigned to those features where a high value led to a negative correlation with DCR, OS6 or TTF3 (Red high value (Class 0); Green color is assigned to those features in which a high value positively correlates with DCR and OS6 (Green high value (Class 1). For IO/IOCT, the high value means the chemo and IO combination therapy.